We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+8.42%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$730M
AUM Growth
+$103M
(+16%)
Cap. Flow
+$65.4M
Cap. Flow
% of AUM
8.96%
Top 10 Holdings %
Top 10 Hldgs %
8.74%
Holding
1,126
New
399
Increased
185
Reduced
164
Closed
376
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$7.61M |
| 2 |
Union Pacific
UNP
|
+$6.16M |
| 3 |
McDonald's
MCD
|
+$6.05M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$5.83M |
| 5 |
AbbVie
ABBV
|
+$5.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Aon
AON
|
+$6.07M |
| 2 |
US Bancorp
USB
|
+$5.86M |
| 3 |
Applied Materials
AMAT
|
+$4.88M |
| 4 |
Occidental Petroleum
OXY
|
+$4.37M |
| 5 |
CSX Corp
CSX
|
+$3.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Consumer Discretionary | 15.57% |
| 3 | Financials | 13.9% |
| 4 | Industrials | 12.85% |
| 5 | Healthcare | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Aurinia Pharmaceuticals
AUPH
$2.11B
| $90.4K | 0.01% |
+10,671
| New | +$85.5K |
|
|
AXIA
727
DELISTED
AXIA Energia
AXIA
| $84.5K | 0.01% |
+14,360
| New | +$83.9K |
|
|
BRSP
728
BrightSpire Capital
BRSP
$648M
| $79.4K | 0.01% |
15,718
+5,377
| +52% | +$27.2K |
|
729
Capitol Federal Financial
CFFN
$1.1B
| $78.4K | 0.01% |
12,860
-17,905
| -58% | -$101K |
|
730
Mizuho Financial
MFG
$130B
| $76.8K | 0.01% |
+13,805
| New | +$71.6K |
|
731
Amprius Technologies
AMPX
$1.73B
| $75K | 0.01% |
+17,811
| New | +$50.1K |
|
732
Gerdau
GGB
$9.7B
| $74.1K | 0.01% |
25,377
-85,058
| -77% | -$233K |
|
733
Array Technologies
ARRY
$855M
| $72.9K | 0.01% |
+12,351
| New | +$75K |
|
734
The Honest Company
HNST
$586M
| $69.5K | 0.01% |
13,657
+4
| +0% | +$19 |
|
735
ReNew
RNW
$2.25B
| $69.4K | 0.01% |
+10,039
| New | +$65.6K |
|
736
JELD-WEN Holding
JELD
$164M
| $68.9K | 0.01% |
+17,573
| New | +$78.3K |
|
737
Ultrapar
UGP
$6.54B
| $65.7K | 0.01% |
20,043
+2,884
| +17% | +$8.74K |
|
738
B&G Foods
BGS
$286M
| $65.3K | 0.01% |
15,438
-5,943
| -28% | -$31K |
|
739
Planet Labs
PL
$8.53B
| $62.9K | 0.01% |
+10,316
| New | +$42.1K |
|
740
Lifestance Health
LFST
$4.14B
| $62.8K | 0.01% |
+12,145
| New | +$72.8K |
|
741
NovaGold Resources
NG
$3.33B
| $61.7K | 0.01% |
+15,094
| New | +$56.5K |
|
|
VZLA
742
Vizsla Silver
VZLA
$1.31B
| $59.5K | 0.01% |
+20,221
| New | +$52.7K |
|
743
Clarivate
CLVT
$1.16B
| $52.7K | 0.01% |
12,255
-25,607
| -68% | -$103K |
|
744
Vaalco Energy
EGY
$594M
| $51K | 0.01% |
+14,122
| New | +$49K |
|
745
Cytek Biosciences
CTKB
$546M
| $50.1K | 0.01% |
+14,730
| New | +$49.1K |
|
|
SFIX
746
Stitch Fix
SFIX
$560M
| $42.5K | 0.01% |
+11,489
| New | +$43K |
|
747
Banco Bradesco
BBD
$36.7B
| $32.6K | ﹤0.01% |
10,541
-19,332
| -65% | -$50.9K |
|
748
Companhia Siderúrgica Nacional
SID
$1.23B
| $28.1K | ﹤0.01% |
+20,107
| New | +$31.1K |
|
|
IAUX
749
i-80 Gold Corp
IAUX
$1.4B
| $24.9K | ﹤0.01% |
29,644
| – | – |
|
750
Humacyte
HUMA
$194M
| $24.3K | ﹤0.01% |
+11,611
| New | +$22.3K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
MA
TCM
HBWM
Aigen Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, Aigen Investment Management held 1,126 positions worth $730M, up 16% from $627M the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Aigen Investment Management deployed $65.4M of net new capital in Q2 2025, opening 399 new positions and adding to 185 existing holdings. Its largest new stake was Amphenol: 93,074 shares worth $9.19M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was US Bancorp, an estimated $5.86M trimmed.
- Aigen Investment Management's largest Q2 2025 buy was Amphenol: 93,074 shares worth $9.19M.
- Aigen Investment Management added most to AbbVie in Q2 2025, an estimated $5.51M increase.
- Aigen Investment Management's biggest Q2 2025 reduction was US Bancorp, cutting an estimated $5.86M.
- Aigen Investment Management fully exited Aon in Q2 2025, selling an estimated $6.07M.
- Aigen Investment Management's ten largest holdings make up 8.7% of its $730M portfolio in Q2 2025.
- Aigen Investment Management opened 399 new positions and closed 376 in Q2 2025.
- Aigen Investment Management's portfolio value rose 16% quarter-over-quarter to $730M.
Based on Aigen Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.